Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move
across top level links and expand / close menus in sub levels. Up and Down arrows will open main level
menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab
will move on to the next part of the site rather than go through menu items.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Join the brightest minds in regulatory at the annual Regulatory Convergence. See the global regulatory community in action. Intensive workshops. Topical sessions. Meet ups with regulators. This is where it all comes together.
For 20 years, our flagship publication, Fundamentals of US Regulatory Affairs, has been giving regulatory professionals the insights and answers they need, right at their fingertips.
There are hundreds of RAC testing centers available worldwide. Any of the four RAC exams (US, EU, CAN or Global) may be taken at any location. Find an upcoming exam at a location near you.
Posted 26 June 2012 | By Alexander Gaffney, RAC
The US Food and Drug Administration (FDA) said it is withdrawing a guidance document published in June 2010 in light of the document no longer reflecting its current thinking on the topic.
In its 26 June 2012 Federal Register posting, FDA said its guidance, "Lupus Nephritis Caused by Systemic Lupus Erythematosus-Developing Medical Products for Treatment," was being withdrawn immediately.
Systemic Lupus Erythamatosus is an autoimmune disease in which the body's immune system attacks cells and tissues within the body. This can cause a condition known as lupus nephritis, which is characterized by the inflammation of the kidney. FDA did not offer any explanation as to why it was withdrawing the guidance, and what could have changed between June 2010 and June 2012 to differently inform its thought process.
There are no public comments listed in the Regulations.gov web docket for the 2010 notice, implying FDA came to its decision by its own accord or through non-public comments.
FDA - Guidance for Industry; Withdrawal: Lupus Nephritis Caused By Systemic Lupus Erythematosus--Developing Medical Products for Treatment
Tags: SLE, Lupus, Withdrawal, Latest News, guidance
Regulatory Focus newsletters
All the biggest regulatory news and happenings.